Medical and Pharmaceutical BriaCell transfers cancer immunotherapy asset to BriaPro in USD$1.18 million deal BriaCell originally licensed the technology from the University of Maryland Joseph MortonApril 2, 2026
AI and Autonomy NetraMark demonstrates efficacy of AI to help with clinical trials AI analyzes huge amounts of data, finds patterns, and makes decisions on its own Joseph MortonMarch 11, 2024